Tuesday 22 November 2022

Kwality Pharmaceuticals

Reasons for buying:

Buy PE was reasonable at 7.9 and the 10-year median PE is 22.

The 5-year earnings average is 104% and earnings increasing since 2014.

Return on equity is good at 99.05% but the 5-year average is 37.25%.

The market cap of the company is ₹3,560 Cr.

The debt of the company is 54.01 Cr with ₹12.95 Cr cash.

Buy date: 23-N0v-2022

Qty: 29 Buy Price: 343.5 Buy EPS: ₹43.46 Buy PE: 7.9

Will add to stock only if earnings rise and price drops.

Kwality Pharmaceuticals is an India-based pharmaceutical company. it is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables. It also manufactures veterinary pharmaceutical products.

No comments:

Post a Comment